Zotefoams PLC Director/PDMR Shareholding (5960Z)
January 12 2024 - 11:13AM
UK Regulatory
TIDMZTF
RNS Number : 5960Z
Zotefoams PLC
12 January 2024
Zotefoams plc
("Zotefoams" or "Company")
Director / PDMR Shareholding
12 January 2024 - Zotefoams, a world leader in cellular
materials technology, announces that it has been informed that a
number of transactions in ordinary shares of 5 pence each in the
Company ("Ordinary Shares") have been undertaken on behalf of Gary
McGrath, Chief Financial Officer, which includes a sale of Ordinary
Shares out of a general investment account and subsequent purchase
of Ordinary Shares into an ISA account for tax planning purposes.
The table below sets out further information on the transactions,
which in aggregate amounts to a net sale of 394 Ordinary
Shares.
Following these transactions, Gary McGrath's beneficial interest
in the Company is 100,492 Ordinary Shares, representing
approximately 0.2% per cent. of the Company's issued share
capital.
- Ends -
Enquiries:
Zotefoams plc +44 (0) 208 664 1600
David Stirling, Group CEO
Gary McGrath, Group CFO
IFC Advisory +44 (0) 203 934 6630
Graham Herring
Tim Metcalfe
Zach Cohen
The information below (set out in accordance with the
requirements of EU Market Abuse Regulation) provides further
detail:
1 Details of the person discharging managerial responsibilities/person
closely associated
a) Name Gary McGrath
================================
2 Reason for the notification
a) Position/status PDMR, Chief Financial Officer
================================
b) Initial notification Initial Notification
/Amendment
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name Zotefoams PLC
b) LEI 213800B6P256B5XN8D32
================================
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
a) Description of Ordinary Shares of 5 pence each
the financial
instrument, type
of instrument
Identification
code
================================
b) Nature of the 1) Sale of Ordinary Shares
transaction 2) Sale of Ordinary Shares
3) Sale of Ordinary Shares
4) Purchase of Ordinary Shares into Mr
McGrath's ISA account
c) Price(s) and volume(s) Price(s) Volume(s)
1) GBP2.6896 177
2) GBP3.0066 191
3) GBP3.3827 889
4) GBP3.4560 863
================================ ===============================
d) Aggregated information
n/a - each a single transaction
- Aggregated volume
- Aggregated price
e) Date of the transaction 1) 1 July 2022
2) 1 September 2022
3) 25 September 2023
4) 26 September 2023
================================
f) Place of the transaction London Stock Exchange, Main Market (XLON)
=== ================================ ===============================================
About Zotefoams plc
Zotefoams plc (LSE - ZTF) is a world leader in cellular
materials technology delivering optimal material solutions for the
benefit of society. Utilising a variety of unique manufacturing
processes, including environmentally friendly nitrogen expansion
for lightweight AZOTE(R) polyolefin and ZOTEK(R) high-performance
foams, Zotefoams sells to diverse markets worldwide. Zotefoams uses
its own cellular materials to manufacture T-FIT(R) advanced
insulation for demanding industrial markets. Zotefoams also owns
and licenses patented microcellular foam technology to reduce
plastic use in extrusion applications and for ReZorce(R)
mono-material recyclable barrier packaging.
Zotefoams is headquartered in Croydon, UK, with additional
manufacturing sites in Kentucky, USA and Brzeg, Poland (foam
manufacture), Oklahoma, USA (foam products manufacture and
conversion), Massachusetts, USA (MuCell Extrusion) and Jiangsu
Province, China (T-FIT).
AZOTE(R) , ZOTEK(R) , ReZorce(R) and T-FIT(R) are registered
trademarks of Zotefoams plc.
www.zotefoams.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHEAKFAFSELEFA
(END) Dow Jones Newswires
January 12, 2024 12:13 ET (17:13 GMT)
Zotefoams (LSE:ZTF)
Historical Stock Chart
From Apr 2024 to May 2024
Zotefoams (LSE:ZTF)
Historical Stock Chart
From May 2023 to May 2024